In this study, we further reveal that LEF1 could promote the proliferation, migration, invasion and EMT of ESCC, suggesting that the LEF1 could be a therapeutic target for the treatment of ESCC. This evidence concerns the gene LEF1 and esophageal squamous cell carcinoma.